4.41
-0.12 (-2.65%)
-0.12 (-2.65%)
Upgrade to Real-Time
Afterhours (Closed)
Low
3.15
High
9.00
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Zynerba Pharmaceuticals Inc | ZYNE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.12 | -2.65% | 4.41 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.51 | 4.38 | 4.61 | 4.41 | 4.53 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 4.30 | 4.46 | 0.16 | 1 | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,064 | 737,649 | $ 4.45 | $ 3,279,066 | - | 3.15 - 9.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:32:15 | 25 | $ 4.46 | USD |
Period:
Draw Mode:
Zynerba Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 181.92M | 41.25M | 39.99M | $ - | $ - | -1.93 | -2.90 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 5.90% |
Zynerba Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ZYNE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.63 | 4.77 | 4.325 | 4.57 | 666,785 | -0.22 | -4.75% |
| 1 Month | 5.34 | 5.3419 | 4.325 | 4.78 | 530,796 | -0.93 | -17.42% |
| 3 Months | 4.02 | 6.07 | 3.91 | 5.07 | 1,260,775 | 0.39 | 9.7% |
| 6 Months | 3.52 | 9.00 | 3.40 | 5.31 | 3,332,822 | 0.89 | 25.28% |
| 1 Year | 3.79 | 9.00 | 3.15 | 5.00 | 2,060,983 | 0.62 | 16.36% |
| 3 Years | 7.02 | 16.47 | 2.55 | 6.53 | 1,417,615 | -2.61 | -37.18% |
| 5 Years | 9.11 | 25.95 | 2.55 | 7.61 | 1,034,111 | -4.70 | -51.59% |
Zynerba Pharmaceuticals Description
| Zynerba Pharmaceuticals Inc is a pharmaceutical company that is focused on developing and commercializing proprietary next-generation synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product pipeline consists Zygel which is a pharmaceutically-produced CBD, a non-euphoric cannabinoid, formulated as a patent-protected permeation-enhanced gel for transdermal delivery through the skin and into the circulatory system. |
